Publication | Open Access
Phosphorylation of carbovir enantiomers by cellular enzymes determines the stereoselectivity of antiviral activity.
63
Citations
30
References
1992
Year
ImmunologyCreatine KinaseAntiviral DrugChemical BiologyAntiviral ActivityHuman RetrovirusAntiviral Drug DevelopmentGmp KinaseHiv Reverse TranscriptaseCarbovir EnantiomersBiochemistryNeurovirologyCellular EnzymesVirologyHivPharmacologyAntiviral CompoundNatural SciencesAntiviral ResponseAntiviral TherapyCellular BiochemistryMedicine
Two enantiomers of carbovir, a carbocyclic analog of 2',3'-dideoxyguanosine, were compared with respect to their phosphorylation and the phosphorylation of their nucleotides by mammalian enzymes. 5'-Nucleotidase catalyzed the phosphorylation of (-)-carbovir, which is active against HIV (human immunodeficiency virus), but did not phosphorylate (+)-carbovir. (-)-Carbovir monophosphate was 7,000 times more efficient as a substrate for GMP kinase than was (+)-carbovir monophosphate. Pyruvate kinase, phosphoglycerate kinase, and creatine kinase phosphorylated both enantiomers of carbovir diphosphate at similar rates. Nucleoside-diphosphate kinase preferentially phosphorylated the (-)-enantiomer. Both enantiomers of carbovir triphosphate were substrates and alternative substrate inhibitors of HIV reverse transcriptase. Thus, the contrasting HIV-inhibitory activities of carbovir enantiomers were due to differential phosphorylation by cellular enzymes and not due to enantioselectivity of HIV reverse transcriptase.
| Year | Citations | |
|---|---|---|
Page 1
Page 1